Nuvation Bio Stock Investor Sentiment

NUVB Stock  USD 2.14  0.07  3.17%   
About 61% of Nuvation Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Nuvation Bio suggests that many traders are alarmed. The current market sentiment, together with Nuvation Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Nuvation Bio stock news signals to limit their universe of possible portfolio assets.
  
a day ago at www.macroaxis.com         
Acquisition by Cui Xiangmin of 967100 shares of Nuvation Bio subject to Rule 16b-3
Macroaxis News
3 days ago at thelincolnianonline.com         
Nuvation Bio Shares Down 2.5 percent Time to Sell?
news
few days ago at news.google.com         
Jones Trading sets 10 target for Nuvation Bio stock with Buy rating - Investing.com
Google News at Macroaxis
six days ago at news.google.com         
Q1 Earnings Estimate for Nuvation Bio Issued By Wedbush - Defense World
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Nuvation Bio Inc. Among the Best NYSE Penny Stocks to Buy According to Analysts
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Kathryn Falberg of 43000 shares of Nuvation Bio at 1.9526 subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Nuvation Bio Reports Transformative Year in 2024 - TipRanks
Google News at Macroaxis
over a week ago at businesswire.com         
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updat...
businesswire News
over a week ago at gurufocus.com         
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business ...
Gurufocus Stories at Macroaxis
over a week ago at seekingalpha.com         
Nuvation Bio GAAP EPS of -0.15 misses by 0.01, revenue of 5.71M
seekingalpha News
over a week ago at thelincolnianonline.com         
Nuvation Bio Receives Outperform Rating from Wedbush
news
over a week ago at kalkinemedia.com         
How Has Nuvation Bio Positioned Itself in the Oncology Market?
news
over a week ago at kalkinemedia.com         
Acquisition by Gary Hattersley of 500000 shares of Nuvation Bio at 1.97 subject to Rule 16b-3
news
over a week ago at finance.yahoo.com         
Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
Yahoo News
over a week ago at gurufocus.com         
Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Nuvation Bio that are available to investors today. That information is available publicly through Nuvation media outlets and privately through word of mouth or via Nuvation internal channels. However, regardless of the origin, that massive amount of Nuvation data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nuvation Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nuvation Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nuvation Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nuvation Bio alpha.

Nuvation Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Nuvation Stock analysis

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities